This Q&A with George Sawaya, MD, explores new cervical cancer screening guidelines issued in January 2026, which recommend at ...

Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...

In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic prostate biopsies outperformed the standard approach of ...

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...

Looking for signs of the cancer in a more convenient way could help women access the test and prevent the disease occurring, ...

A groundbreaking blood test for colorectal cancer screening has received approval from the U.S. Food and Drug Administration (FDA), offering the potential to revolutionize early detection for one of ...

Researchers and professionals stress that any rollout should be done cautiously, and with human supervision. Follow us on ...

Researchers with the Virginia Cancer Screening Research Network are looking for participants for a study that’s putting a new way of screening for cancer to the test. Through the Vanguard Study, they ...

The case for screening is even more urgent in India. According to GLOBOCAN estimates from 2022, India recorded roughly 1.4 ...

Objective To compare the diagnostic accuracy of minipad collected menstrual blood versus clinician collected cervical samples to test for human papillomavirus (HPV) in the detection of cervical ...